Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Farber · SciRah

Researcher profile · Semantic Scholar

R. Farber

Share profile

R. Farber — researcher profile on SciRah

h-index: 13
Works: 28
Citations: 498

Most-cited papers

Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorder.
D. Feifel, R. Farber, B. Clementz, W. Perry +1 more
2004Biological Psychiatry97 citations
Semantic Scholar
Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency.
Adina F. Turcu, Joanna L. Spencer-Segal, R. Farber, Rosa Luo +6 more
2016Journal of Clinical Endocrinology and Metabolism53 citations Open access
Semantic Scholar
A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjects.
A. Madan, Z. O'Brien, Jianyun Wen, C. O'Brien +7 more
2009British Journal of Clinical Pharmacology53 citations Open access
Semantic Scholar
Clinical development of valbenazine for tics associated with Tourette syndrome
R. Farber, A. Angelov, Kristine Kim, T. Carmack +2 more
2021Expert Review of Neurotherapeutics42 citations Open access
Semantic Scholar
Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
R. Auchus, K. Sarafoglou, P. Fechner, M. Vogiatzi +7 more
2021Journal of Clinical Endocrinology and Metabolism39 citations Open access
Semantic Scholar
Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
M. Scharf, J. Black, Steven G. Hull, R. Landin +1 more
2007Sleep39 citations Open access
Semantic Scholar
Efficacy and tolerability of indiplon in older adults with primary insomnia.
J. Walsh, A. Moscovitch, J. Burke, R. Farber +1 more
2007Sleep Medicine28 citations
Semantic Scholar
Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia
R. Newfield, K. Sarafoglou, P. Fechner, Natalie J. Nokoff +8 more
2023Journal of Clinical Endocrinology and Metabolism26 citations Open access
Semantic Scholar
Efficacy and Safety of Oral Budesonide Suspension (OBS) in Pediatric Subjects With Eosinophilic Esophagitis (EoE): Results From the Double-Blind, Placebo-Controlled PEER Study
S. Gupta, M. Collins, Jeffery D. Lewis, R. Farber
201125 citations Open access
Semantic Scholar
Efficacy and tolerability of indiplon in transient insomnia.
R. Rosenberg, T. Roth, M. Scharf, D. Lankford +1 more
2007Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine24 citations Open access
Semantic Scholar
Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.
T. Roth, G. Zammit, M. Scharf, R. Farber
2007Sleep23 citations Open access
Semantic Scholar
Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
R. Lydiard, D. Lankford, D. Seiden, R. Landin +2 more
2006Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine23 citations Open access
Semantic Scholar
Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers*
R. Farber, P. Burke
2008Current Medical Research and Opinion15 citations
Semantic Scholar
Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
S. Gupta, M. Hill, J. Vitanza, R. Farber +3 more
2022Journal of Pediatric Gastroenterology and Nutrition - JPGN9 citations Open access
Semantic Scholar
OR25-03 The Effects of Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, on Adrenal Androgens and Precursors in Patients with Classic Congenital Adrenal Hyperplasia: Results from A Multiple-Dose Phase 2 Study
R. Auchus, K. Sarafoglou, P. Fechner, M. Vogiatzi +4 more
2020Journal of the Endocrine Society1 citations Open access
Semantic Scholar
PII‐29
Raymond Miller, D. Ouellet, R. Farber, P. Chappell +2 more
20061 citations
Semantic Scholar
PI‐39
B. Corrigan, R. Miller, P. Chappell, R. Farber +1 more
20061 citations
Semantic Scholar
PIII‐40
D. Ouellet, P. Chappell, R. Farber, B. Corrigan
20061 citations
Semantic Scholar
Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
R. Newfield, K. Sarafoglou, P. Fechner, N. Nokoff +7 more
2023Endocrine Abstracts0 citations
Semantic Scholar
Response to Crinecerfont Treatment in Adults with Classic Congenital Adrenal Hyperplasia Is Correlated with Elevated Baseline Hormone Levels But Not Glucocorticoid Dose
R. Auchus, K. Sarafoglou, F. Y., M. Vogiatzi +5 more
2023Endocrine Abstracts0 citations
Semantic Scholar
OR18-4 Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
R. Auchus, Jean Chan, R. Farber, P. Fechner +7 more
2022Journal of the Endocrine Society0 citations Open access
Semantic Scholar
Real-World Evidence of Clinical Outcomes in Patients With Assumed Classic Congenital Adrenal Hyperplasia in the United States
M. Farrar, R. Farber, Ginny P. Sen, C. Yonan +1 more
2021Journal of the Endocrine Society0 citations Open access
Semantic Scholar
Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
M. Farrar, S. Ali, J. Bryce, F. Baronio +6 more
2021Journal of the Endocrine Society0 citations Open access
Semantic Scholar
Changes in Adrenal and Gonadal Androgens After 14-Day Treatment With CRF1 Receptor Antagonist, Crinecerfont (NBI-74788), in Men With Classic 21-Hydroxylase Deficiency
Xin He, K. Sarafoglou, P. Fechner, M. Vogiatzi +6 more
2021Journal of the Endocrine Society0 citations Open access
Semantic Scholar
MON-183 Adrenal Androgen Control and Steroidal Side Effects in Adolescents and Adults with Congenital Adrenal Hyperplasia Treated with Glucocorticoids
H. Falhammar, R. Farber, J. Chan, M. Farrar +3 more
2020Journal of the Endocrine Society0 citations Open access
Semantic Scholar
Crinecerfont (NBI-74788), a novel CRF1 receptor antagonist, reduces adrenal androgens and precursors in patients with classic congenital adrenal hyperplasia: Results from a phase 2, multiple-dose study
R. Auchus, K. Sarafoglou, P. Fechner, M. Vogiatzi +4 more
2020Endocrine Abstracts0 citations
Semantic Scholar
Indiplon in the Treatment of Chronic Insomnia in Women
R. Farber, J. Black, R. Landin, D. Ross
20060 citations
Semantic Scholar
Indiplon in the Treatment of Chronic Insomnia in Elderly Women
R. Farber, J. Burke, D. Ross
20060 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Auchus×10
Invite
R. Auchus — researcher profile on SciRah
Eiry W. Roberts×8
Invite
Eiry W. Roberts — researcher profile on SciRah
K. Sarafoglou×8
Invite
K. Sarafoglou — researcher profile on SciRah
M. Vogiatzi×8
Invite
M. Vogiatzi — researcher profile on SciRah

×8

Invite

Julia Sturgeon — researcher profile on SciRah

Invite

J. Chan — researcher profile on SciRah

Invite

P. Fechner — researcher profile on SciRah

Invite

N. Giri — researcher profile on SciRah

Invite

M. Scharf — researcher profile on SciRah

Invite

R. Landin — researcher profile on SciRah

Invite

T. Roth — researcher profile on SciRah

Invite

P. Chappell — researcher profile on SciRah